Actionable news
0
All posts from Actionable news
Actionable news in TEVA: TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES,

Will Teva Pharmaceuticals (TEVA) Stock Improve on Q2 Beat?

NEW YORK (TheStreet) -- Teva Pharmaceuticals (TEVA) posted second quarter results that surpassed analysts expectations before today's opening bell.

Teva reported earnings of $1.25 per share, beating analysts projected $1.20 per share. The Israeli pharmaceutical company's revenue increased 1% year-over-year to $5 billion, exceeding analysts expected $4.87 billion.

For the same quarter last year, Teva posted earnings of $1.43 per share on revenue of $4.97 billion.

"Going forward we are focused on the integration of Actavis Generics, delivering on our operational and financial...


More